Blog

Oct
18
RELIABLE MONITORING OF ANTIVIRAL THERAPY FOR HEPATITIS C INFECTIONS

Jena, September 14, 2017 - Infection with the hepatitis C virus (HCV) is the most frequent cause of liver cell carcinoma and liver transplantation in Europe. In addition to liver cirrhosis, the possible sequelae of a chronic infection. An antiviral therapy to eliminate the hepatitis C virus now allows the treatment and cure of the infection. The standardized approach to monitoring the therapeutic efficacy consists of a repeated quantitative measurement of the patient's HCV RNA level. This requires the use of a highly sensitive HCV RNA assay.

The CE-IVD certified workflow Analytik Jena with the INSTANT Virus RNA / DNA kit for nucleic acid purification in combination with the RoboGene ® HCV RNA Quantification Kit 3.0 for nucleic acid detection on the real-time PCR cycler qTOWER³ this provides a reliable solution. With a detection limit of 17 IU / ml, the RoboGene ® HCV RNA Quantification Kit 3.0 allows a high-sensitivity quantitative analysis of HCV RNA even with varying viral loads in the high to low-positive concentration range. This allows monitoring of the entire course of the therapy and thus supports successful therapy.

More information about requirements and solutions for reliable monitoring of therapy monitoring can be downloaded at HTTPS://WWW.ANALYTIK-JENA.DE/EN/CLINICAL.HTML.